# FDA recall D-687-2013

> **Sun Pharmaceutical Industries Inc.** · Class II · drug recall initiated 2013-05-21.

## Product

Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton), NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc.

## Reason for recall

Crystallization; crystallized nimodipine

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-687-2013
- **Recalling firm:** Sun Pharmaceutical Industries Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-05-21
- **Report date:** 2013-07-17
- **Termination date:** 2014-08-25

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Cranbury, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-687-2013

## Citation

> AI Analytics. FDA recall D-687-2013. Retrieved 2026-05-29 from https://api.ai-analytics.org/recall/D-687-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*